Pharmaron Beijing Co Ltd (300759) — Cash Flow Quality Index
Pharmaron Beijing Co Ltd (300759) has a Cash Flow Quality Index of 2.36x as of September 2025. Operating cash flow of CN¥1.04 Billion exceeds net income of CN¥439.52 Million, indicating high earnings quality where cash backs reported profits. Explore Pharmaron Beijing Co Ltd (300759) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pharmaron Beijing Co Ltd Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for Pharmaron Beijing Co Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Pharmaron Beijing Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Pharmaron Beijing Co Ltd (2014–2024)
Year-by-year earnings quality comparison for Pharmaron Beijing Co Ltd. For live market cap and the full company financial profile, see market cap of Pharmaron Beijing Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.50x | CN¥2.58 Billion | CN¥1.71 Billion | ▼ -12.6% |
| 2023 | 1.72x | CN¥2.75 Billion | CN¥1.60 Billion | ▲ +8.5% |
| 2022 | 1.58x | CN¥2.14 Billion | CN¥1.35 Billion | ▲ +24.8% |
| 2021 | 1.27x | CN¥2.06 Billion | CN¥1.62 Billion | ▼ -11.6% |
| 2020 | 1.44x | CN¥1.65 Billion | CN¥1.15 Billion | ▼ -18.7% |
| 2019 | 1.77x | CN¥938.59 Million | CN¥530.67 Million | ▼ -18.7% |
| 2018 | 2.17x | CN¥737.26 Million | CN¥339.03 Million | ▼ -10.6% |
| 2017 | 2.43x | CN¥552.22 Million | CN¥227.02 Million | ▲ +82.5% |
| 2016 | 1.33x | CN¥235.77 Million | CN¥176.91 Million | ▼ -54.6% |
| 2015 | 2.94x | CN¥216.94 Million | CN¥73.85 Million | ▲ +408.3% |
| 2014 | 0.58x | CN¥12.13 Million | CN¥21.00 Million | — |